• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描技术在吸烟的偏执型精神分裂症患者活体大脑中 2-[¹⁸F]氟-3-(2(S)-氮杂环丁烷甲氧基)吡啶(2-[¹⁸F]FA)的应用经验。

Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.

机构信息

Division of Nuclear Medicine, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Johns Hopkins Outpatient Center, Baltimore, Maryland 21287-0807, USA.

出版信息

Synapse. 2012 Apr;66(4):352-68. doi: 10.1002/syn.21520. Epub 2011 Dec 29.

DOI:10.1002/syn.21520
PMID:22169936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3445266/
Abstract

Utilizing postmortem data (Breese et al. [2000] Neuropsychopharmacology 23:351-364), we hypothesized that the densities of high-affinity neuronal α4β2 nicotinic acetylcholine receptors (nAChRs) in the brain exist in a continuum from highest to lowest as follows: smokers without schizophrenia > smokers with schizophrenia > nonsmokers without schizophrenia > nonsmokers with schizophrenia. Application of the Kruskal-Wallis Test (Statacorp, 2003) to the postmortem data (Breese et al. [2000] Neuropsychopharmacology 23:351-364) confirmed the hypothesized order in the cortex and the hippocampus and attained significance in the caudate and the thalamus. Positron emission tomography (PET) was performed for 60 min at 6 h after the intravenous administration of 444 megabequerels [MBq] (12 mCi) 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA), a radiotracer for high-affinity neuronal α4β2 nAChRs, as a bolus plus continuous infusion to 10 adults (seven men and three women) (six smokers including five with paranoid schizophrenia and four nonsmokers) ranging in age from 22 to 56 years (mean 40.1, standard deviation 13.6). The thalamic nondisplaceable binding potential (BP(ND) ) was 1.32 ± 0.19 (mean ± standard deviation) for healthy control nonsmokers; 0.50 ± 0.19 for smokers with paranoid schizophrenia; and 0.51 for the single smoker without paranoid schizophrenia. The thalamic BP(ND) s of nonsmokers were significantly higher than those of smokers who smoked cigarettes a few hours before the scans (P = 0.0105) (StataCorp, 2003), which was likely due to occupancy of nAChRs by inhaled nicotine in smokers. Further research is needed to rule out the effects of confounding variables.

摘要

利用尸检数据(Breese 等人,[2000]Neuropsychopharmacology 23:351-364),我们假设大脑中高亲和力神经元α4β2 烟碱型乙酰胆碱受体(nAChR)的密度从最高到最低呈连续分布,具体如下:无精神分裂症的吸烟者>有精神分裂症的吸烟者>无精神分裂症的不吸烟者>有精神分裂症的不吸烟者。Kruskal-Wallis 检验(Statacorp,2003)应用于尸检数据(Breese 等人,[2000]Neuropsychopharmacology 23:351-364)证实了皮质和海马中假设的顺序,并在尾状核和丘脑达到了显著水平。在静脉注射 444 兆贝克勒尔(MBq)(12 毫居里)2-[¹⁸F]氟-3-(2(S)-氮杂环丁烷甲氧基)吡啶(2-[¹⁸F]FA)6 小时后,对 10 名成年人(7 名男性和 3 名女性)(包括 5 名偏执型精神分裂症患者的 6 名吸烟者和 4 名不吸烟者)进行了 60 分钟的正电子发射断层扫描(PET),这是一种用于高亲和力神经元α4β2 nAChR 的放射性示踪剂,以推注加连续输注的方式进行。年龄从 22 岁到 56 岁不等(平均 40.1,标准差 13.6)。健康对照不吸烟者的丘脑不可置换结合潜能(BP(ND))为 1.32±0.19(平均值±标准差);偏执型精神分裂症患者的吸烟者为 0.50±0.19;而唯一一位没有偏执型精神分裂症的吸烟者为 0.51。不吸烟者的丘脑 BP(ND)明显高于扫描前几小时吸烟的吸烟者(P=0.0105)(StataCorp,2003),这可能是由于吸烟者吸入的尼古丁占据了 nAChR。需要进一步的研究来排除混杂变量的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/b161b7e399d0/nihms349035f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/650b1e69067b/nihms349035f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/e0badeab9b04/nihms349035f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/b161b7e399d0/nihms349035f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/650b1e69067b/nihms349035f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/e0badeab9b04/nihms349035f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0d/3445266/b161b7e399d0/nihms349035f3.jpg

相似文献

1
Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.正电子发射断层扫描技术在吸烟的偏执型精神分裂症患者活体大脑中 2-[¹⁸F]氟-3-(2(S)-氮杂环丁烷甲氧基)吡啶(2-[¹⁸F]FA)的应用经验。
Synapse. 2012 Apr;66(4):352-68. doi: 10.1002/syn.21520. Epub 2011 Dec 29.
2
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.吸烟者和非吸烟者活体人脑中使用(S)-5-[(123)I]碘-3-(2-氮杂环丁烷基甲氧基)吡啶的单光子发射计算机断层扫描经验
Synapse. 2009 Apr;63(4):339-58. doi: 10.1002/syn.20611.
3
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.吸烟者的烟碱型乙酰胆碱受体密度高于非吸烟者:一项使用2-18F-FA-85380的PET研究。
J Nucl Med. 2008 Oct;49(10):1628-35. doi: 10.2967/jnumed.108.050716. Epub 2008 Sep 15.
4
Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain.二手烟对大脑中烟碱型乙酰胆碱受体占有率的影响。
Arch Gen Psychiatry. 2011 Sep;68(9):953-60. doi: 10.1001/archgenpsychiatry.2011.51. Epub 2011 May 2.
5
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.2-氟-3-[2(S)-2-氮杂环丁烷基甲氧基]吡啶的合成及其在体内对烟碱型乙酰胆碱受体的结合特性:一种用于烟碱型受体的新型正电子发射断层扫描配体。
J Med Chem. 1999 Jun 17;42(12):2251-9. doi: 10.1021/jm9910223.
6
Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.尼古丁代谢率低的吸烟者中烟碱受体可用性降低。
J Nucl Med. 2015 Nov;56(11):1724-9. doi: 10.2967/jnumed.115.155002. Epub 2015 Aug 13.
7
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.利用正电子发射断层扫描评估轻度认知障碍和阿尔茨海默病患者大脑中 α4β2* 烟碱型乙酰胆碱受体的可用性降低。
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):515-25. doi: 10.1007/s00259-010-1644-5. Epub 2010 Nov 11.
8
Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).烟碱型乙酰胆碱受体 α4β2 显像剂。第三部分。3-(2-(S)-氮杂环丁烷甲氧基)-5-(3'-18F-丙基)吡啶(18F-尼非佐地定)的合成与生物学评价。
Nucl Med Biol. 2011 Nov;38(8):1183-92. doi: 10.1016/j.nucmedbio.2011.05.005. Epub 2011 Aug 9.
9
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.吸烟诱导β2-烟碱型乙酰胆碱受体占有率的定量:不可置换结合的估计。
J Nucl Med. 2010 Aug;51(8):1226-33. doi: 10.2967/jnumed.109.072447. Epub 2010 Jul 21.
10
PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.使用具有最佳脑内动力学特性的放射性配体 18F-AZAN 对人类高亲和力 α4β2 烟碱型乙酰胆碱受体进行 PET 成像。
J Nucl Med. 2013 Aug;54(8):1308-14. doi: 10.2967/jnumed.112.108001. Epub 2013 Jun 25.

引用本文的文献

1
Cholinergic system in schizophrenia: A systematic review and meta-analysis.精神分裂症中的胆碱能系统:一项系统评价与荟萃分析。
Mol Psychiatry. 2025 May 20. doi: 10.1038/s41380-025-03023-y.
2
Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer's Disease.烟碱型乙酰胆碱受体与小胶质细胞作为阿尔茨海默病的治疗和成像靶点。
Molecules. 2022 Apr 27;27(9):2780. doi: 10.3390/molecules27092780.
3
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome.脆性X综合征男性患者大脑代谢型谷氨酸受体5亚型表达降低

本文引用的文献

1
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.利用正电子发射断层扫描评估轻度认知障碍和阿尔茨海默病患者大脑中 α4β2* 烟碱型乙酰胆碱受体的可用性降低。
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):515-25. doi: 10.1007/s00259-010-1644-5. Epub 2010 Nov 11.
2
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.吸烟诱导β2-烟碱型乙酰胆碱受体占有率的定量:不可置换结合的估计。
J Nucl Med. 2010 Aug;51(8):1226-33. doi: 10.2967/jnumed.109.072447. Epub 2010 Jul 21.
3
Brain Sci. 2020 Nov 24;10(12):899. doi: 10.3390/brainsci10120899.
4
Radiation dosimetry of the αβ nicotinic receptor ligand (+)-[F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results.αβ烟碱受体配体(+)-[F]氟巴汀的辐射剂量测定:临床前PET/MRI和PET/CT与首次人体PET/CT结果的比较
EJNMMI Phys. 2016 Dec;3(1):25. doi: 10.1186/s40658-016-0160-5. Epub 2016 Oct 21.
5
Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors.用于离子通道连接神经受体成像的精选PET放射性配体:聚焦于GABA、NMDA和nACh受体
Curr Top Med Chem. 2016;16(16):1830-42. doi: 10.2174/1568026616666160315142457.
6
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.烟碱型乙酰胆碱受体功能障碍作为精神分裂症和共病尼古丁成瘾的共同基础:当前趋势与展望。
Schizophr Res. 2016 Mar;171(1-3):1-15. doi: 10.1016/j.schres.2016.01.020. Epub 2016 Jan 21.
7
Molecular substrates of schizophrenia: homeostatic signaling to connectivity.精神分裂症的分子底物:从稳态信号传导到神经连接
Mol Psychiatry. 2016 Jan;21(1):10-28. doi: 10.1038/mp.2015.141. Epub 2015 Sep 22.
8
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.化为乌有?基于烟碱型乙酰胆碱受体改善精神分裂症认知的治疗策略综述
Curr Pharm Des. 2014;20(31):5077-92. doi: 10.2174/1381612819666131216121019.
9
The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects.中枢神经系统药物治疗的策略:人类大脑分布、靶点动力学和治疗效果的转化预测。
Fluids Barriers CNS. 2013 Feb 22;10(1):12. doi: 10.1186/2045-8118-10-12.
10
Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice.基于小鼠全身 PET 成像评估 [18F]Nifene 的生物分布和剂量学。
Nucl Med Biol. 2013 Feb;40(2):289-94. doi: 10.1016/j.nucmedbio.2012.11.004. Epub 2012 Dec 21.
Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors.
用于脑烟碱型乙酰胆碱受体成像的PET放射性配体的临床视角与最新进展
PET Clin. 2009 Jan 1;4(1):89-100. doi: 10.1016/j.cpet.2009.04.014.
4
Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.帕金森病中α4β2* -烟碱型乙酰胆碱受体结合减少及其与轻度认知和抑郁症状的关系。
Arch Gen Psychiatry. 2009 Aug;66(8):866-77. doi: 10.1001/archgenpsychiatry.2009.106.
5
Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.通过正电子发射断层扫描技术开发具有优化成像特性的放射性配体,用于定量检测烟碱型乙酰胆碱受体。
Life Sci. 2010 Apr 10;86(15-16):575-84. doi: 10.1016/j.lfs.2009.02.029. Epub 2009 Mar 18.
6
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.吸烟者和非吸烟者活体人脑中使用(S)-5-[(123)I]碘-3-(2-氮杂环丁烷基甲氧基)吡啶的单光子发射计算机断层扫描经验
Synapse. 2009 Apr;63(4):339-58. doi: 10.1002/syn.20611.
7
Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.精神分裂症,“事实简述”——2008年我们所了解的情况。2. 流行病学与病因学
Schizophr Res. 2008 Jul;102(1-3):1-18. doi: 10.1016/j.schres.2008.04.011. Epub 2008 Jun 2.
8
Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain.吸烟会上调人脑中的α4β2*烟碱型乙酰胆碱受体。
Neurosci Lett. 2008 Jan 3;430(1):34-7. doi: 10.1016/j.neulet.2007.10.011. Epub 2007 Oct 22.
9
Brain imaging research: does the science serve clinical practice?脑成像研究:科学是否服务于临床实践?
Int Rev Psychiatry. 2007 Oct;19(5):541-58. doi: 10.1080/09540260701564849.
10
Consensus nomenclature for in vivo imaging of reversibly binding radioligands.可逆结合放射性配体体内成像的共识命名法。
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. doi: 10.1038/sj.jcbfm.9600493. Epub 2007 May 9.